CERO(Delisted)
CERo Therapeutics·NASDAQ
--
--(--)
CERO fundamentals
During Q2 2025, CERo Therapeutics (CERO) reported revenue of --, a YoY change of 0.00%. Net income was -5.42M, a YoY change of -121.24%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | TTM |
|---|
Start Date | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Feb 14, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | -- |
End Date | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 0 -- | 331.03K -- | 404.78K -- | 376.58K -- | 836.68K -- | 1.29M +288.91% | 2.44M +502.39% | 2.41M +540.97% | 1.54M +83.53% | 1.12M -12.91% | 3.65M +49.89% | 5.15M +113.29% | 4.40M +186.68% | 2.10M +86.90% | 4.95M +35.45% | 4.72M -8.24% | 16.17M -- |
Selling, General and Administrative Expenses | 0 -- | 250.71K -- | 354.78K -- | 326.58K -- | 786.68K -- | 1.37M +447.79% | 638.35K +79.93% | 1.22M +273.77% | 258.01K -67.20% | 103.06K -92.50% | 2.75M +330.94% | 2.43M +99.39% | 2.63M +918.56% | 1.17M +1037.64% | 2.04M -25.74% | 1.97M -19.07% | 7.81M -- |
General and Administrative Expenses | -- -- | 251.71K -- | -- -- | -- -- | -- -- | 2.84M +1028.85% | -- -- | 1.22M -- | 258.01K -- | 103.06K -96.37% | 2.75M -- | 2.43M +99.39% | 2.63M +918.56% | 1.17M +1037.64% | 2.04M -25.74% | 1.97M -19.07% | 7.81M -- |
Research and Development Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.80M -- | 1.19M -- | 1.28M -- | 1.02M -- | 904.01K -49.78% | 2.71M +127.51% | 1.77M +38.88% | 922.98K -9.34% | 2.91M +221.66% | 2.75M +1.46% | 8.36M -- |
Other Operating Expenses | -- -- | 80.32K -- | 50.00K -- | 50.00K -- | 50.00K -- | -85.95K -207.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | 0 -- | -331.03K -- | -404.78K -- | -376.58K -- | -836.68K -- | -1.29M -288.91% | -2.44M -502.39% | -2.41M -540.97% | -1.54M -83.53% | -1.12M +12.91% | -3.65M -49.89% | -5.15M -113.29% | -4.40M -186.68% | -2.10M -86.90% | -4.95M -35.45% | -4.72M +8.24% | -16.17M -- |
Non-Operating Income (Loss) | 0 -- | -385 -- | 26.78K -- | 265.01K -- | 981.65K -- | 1.56M +406183.64% | 16 -99.94% | 321.24K +21.22% | 186.22K -81.03% | -144.01K -109.21% | 1.93M +12046487.50% | 2.70M +740.37% | 174.27K -6.42% | 2.77M +2021.67% | -155.40K -108.06% | -693.52K -125.69% | 2.09M -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 8.14K -- | -- -- | -- -- | -- -- | 3.34M +40902.25% | -- -- | -- -- | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | -385 -- | -- -- | -- -- | -- -- | -- -- | -- -- | 261.82K -- | 186.07K -- | -110.06K -- | 1.80M -- | 2.90M +1007.62% | 170.00K -8.64% | 10.00K +109.09% | 0 -100.00% | 0 -100.00% | 180.00K -- |
Other Non-Operating Income (Loss) | 0 -- | 0 -- | 26.78K -- | 227.90K -- | 661.18K -- | -915.86K -- | -- -- | 0 -100.00% | 0 -100.00% | -62.18K +93.21% | 141.89K -- | -183.44K -- | -147 -- | -630.68K -914.25% | -156.25K -210.12% | -707.30K -285.58% | -1.49M -- |
Net Interest Expense | 0 -- | 0 -- | -- -- | -37.11K -- | -320.48K -- | -2.48M -- | -16 -- | -59.42K -60.12% | -157 +99.95% | -20.09K +99.19% | 14.43K +90312.50% | 16.98K +128.57% | -4.42K -2714.01% | -48.84K -143.11% | -850 -105.89% | -13.78K -181.15% | -67.88K -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -26.99K -- | -- -- | -- -- | -- -- |
Interest Income | 0 -- | 0 -- | -- -- | 37.11K -- | 320.48K -- | 2.48M -- | -- -- | -- -- | 157 -99.95% | 20.09K -99.19% | -- -- | -- -- | 4.42K +2714.01% | 21.85K +8.75% | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | 0 -- | -331.42K -- | -378.00K -- | -111.57K -- | 144.97K -- | 276.02K +183.29% | -2.44M -545.07% | -2.09M -1775.53% | -1.35M -1030.80% | -1.27M -558.36% | -1.73M +29.15% | -2.45M -17.02% | -4.23M -213.33% | 671.89K +153.11% | -5.11M -195.57% | -5.42M -121.24% | -14.08M -- |
Income Tax Expense | 0 -- | -16.87K -- | -- -- | -- -- | 60.46K -- | 538.70K +3293.61% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Current Income Tax | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Deferred Income Tax | -- -- | -69.81K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Income Tax Adjustments | -- -- | 52.94K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | 0 -- | -314.55K -- | -378.00K -- | -111.57K -- | 84.50K -- | -262.68K +16.49% | -2.44M -545.07% | -2.09M -1775.53% | -1.35M -1696.77% | -1.27M -381.65% | -1.73M +29.15% | -2.45M -17.02% | -4.23M -213.33% | 671.89K +153.11% | -5.11M -195.57% | -5.42M -121.24% | -14.08M -- |
Net Income Attributable to Owners of the Company | 0 -- | -314.55K -- | -378.00K -- | -111.57K -- | 84.50K -- | -262.68K +16.49% | -2.44M -545.07% | -2.09M -1775.53% | -1.35M -1696.77% | -1.27M -381.65% | -1.73M +29.15% | -2.45M -17.02% | -4.23M -213.33% | 671.89K +153.11% | -5.11M -195.57% | -5.42M -121.24% | -14.08M -- |
Preferred Stock Dividends | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | -- -- | 2.51M -- | 264.14K -- | 24.70M -- | -- -- |
Other Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 276.84K -- | 84.08K -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | 0 -- | -314.55K -- | -378.00K -- | -111.57K -- | 84.50K -- | -262.68K +16.49% | -2.44M -545.07% | -2.09M -1775.53% | -1.35M -1696.77% | -1.27M -381.65% | -1.73M +29.15% | -2.45M -17.02% | -4.23M -213.33% | -2.11M -67.01% | -5.45M -215.73% | -30.12M -1129.97% | -41.91M -- |
Other Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -315.55K -- | -- -- | -- -- | -- -- | -667.74K -111.61% | -- -- | -2.09M -- | -1.35M -- | -1.27M -89.47% | -1.73M -- | -2.45M -17.02% | -4.23M -213.33% | 671.89K +153.11% | -5.11M -195.57% | -5.42M -121.24% | -14.08M -- |
Basic EPS | 0 -- | -0.01 -- | -0.02 -- | 0 -- | 0 -- | -0.04 -300.00% | -0.27 -1250.00% | -0.23 -- | -0.15 -- | -0.2 -400.00% | -12.24 -4433.33% | -302.32 -131343.48% | -0.09 +40.00% | -0.87 -335.00% | -1.59 +87.01% | -61.71 +79.59% | -64.26 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.23 -- | -0.15 -- | -- -- | -12.24 -- | -302.32 -131343.48% | -0.09 +40.00% | -- -- | -1.59 +87.01% | -61.71 +79.59% | -- -- |
Diluted EPS | 0 -- | -- -- | -0.02 -- | 0 -- | 0 -- | -- -- | -0.27 -1250.00% | -0.23 -- | -0.15 -- | -- -- | -12.24 -4433.33% | -302.32 -131343.48% | -0.09 +40.00% | -- -- | -1.59 +87.01% | -61.71 +79.59% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.23 -- | -0.15 -- | -- -- | -12.24 -- | -302.32 -131343.48% | -0.09 +40.00% | -- -- | -1.59 +87.01% | -61.71 +79.59% | -- -- |
You can ask Aime
No Data
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
